SalivaPrint as a non-invasive diagnostic tool by Esteves, Eduardo et al.
SalivaPrint as a Non-invasive Diagnostic Tool 
Eduardo Esteves a, Igor Cruz b, Ana Cristina Esteves c, Marlene Barros d and Nuno Rosa e 
Universidade Católica Portuguesa, Faculty of Dental Medicine, 
Center for Interdisciplinary Research in Health (CIIS), Portugal 
Keywords:  Saliva Diagnostic, Saliva Protein Profile, Machine Learning Strategies, Health Diagnostic. 
Abstract:  Currently, the molecular diagnosis is based on the quantification of RNA, proteins and metabolites because 
they present changes in their quantity related to clinical situations. The same molecules are not generally 
suitable for early diagnosis or to follow clinical evolution, making necessary strategies to evaluate the 
complete molecular scenario. There are already experimental strategies that allow the determination of total 
protein profiles from saliva samples (the SalivaPrint). The goal of this work is to identify a profile of saliva 
proteins (similar to a fingerprint) and, using computational methods, identify how this profiles changes with 
age and gender. So far it has been possible to collect 79 samples as well as the metadata associated with each 
sample using an electronic questionnaire developed by us. A total protein profile was obtained and their 
association with gender was verified using statistical methods. Currently we are developing the Python scripts 
for automatic data acquiring and normalization. Total protein profiles annotation on a database 
(SalivaPrintDB) and their integration with the factors that affects them using machine learning strategies can 
empower the use of the approach proposed on this work as a tool for monitoring the individual's health status. 
1 INTRODUCTION 
In the last decade, saliva has been studied as a 
noninvasive, easily obtainable fluid, with diagnosis 
potential (Loo et al., 2010). 
Saliva reflects the secretions of the 3 largest 
salivary glands (parotid, submandibular and 
sublingual), smaller salivary glands, crevicular fluid 
and also contains serum components, transported by 
blood capillaries and subsequently transferred by 
diffusion, transport and/or ultrafiltration. The 
presence of serum proteins in saliva enhances its use 
as a systemic health status monitoring tool 
(Castagnola et al., 2017; Kaczor-Urbanowicz et al., 
2017; Kaushik and Mujawar, 2018; Wang, Kaczor-
Urbanowicz, and Wong, 2017). 
We recently described an automated capillary 
electrophoresis-based strategy that allows to obtain a 
salivary protein profile – the SalivaPrint Toolkit 
(Cruz et al., 2018).  
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Since proteins are separated according to their 
molecular mass, changes in peak morphology or 
fluorescence intensity (translated by changes in peak 
height) correspond to changes in the amount of 
proteins or in the type of proteins being expressed. 
The association of clinical and personal data to saliva 
protein signatures, the SalivaPrint, to alterations in 
different health/disease situations, will allow to build 
a powerful framework for the creation of noninvasive 
diagnostic strategies. 
Preliminary results of data extraction 
(SalivaPrint-Toolkit, Cruz et al., 2018) from capillary 
electrophoresis allowed to identify the potential for 
the creation of a SalivaPrint database. 
It is known that some factors such as age, sex, or 
circadian rhythm (Castagnola et al., 2011, 2017; Murr 
et al., 2017), contribute to altering the expression of 
salivary proteins . It is essential to define the signature 
of proteins correspondent to the "healthy individual", 
and simultaneously consider the intra-individual 
variations. 
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Additionally, will be useful to identify potential 
proteins that could reflect the changes in the 
SalivaPrint profiles characteristic of different 
situations. Data on proteins in saliva associated with 
disease and health is already extensive. Our group 
compilated this information in SalivaTecDB database 
(http://salivatec.viseu.ucp.pt/salivatec-db, Arrais et 
al., 2013; Rosa et al., 2012), which is an important 
support for the identification of proteins that may 
potentially be associated with certain signatures. 
SalivaTecDB has currently stored more than 4000 
human salivary proteins and is constantly being 
updated.  
The profile of salivary proteins, expressed in 
different situations, has the potential of being used for 
noninvasive diagnosis. The objectives of this work 
are: 
1- Establish the Health-SalivaPrint(s). The factors 
that influence the protein profile of saliva in healthy 
individuals will be considered. 
2- Build a SalivaPrint database. These profiles 
will posteriorly be used for the development of a tool 
for heath monitoring using machine learning 
strategies. 
2 MOTIVATION 
Nowadays, molecular diagnosis is based on the 
quantification of RNA, proteins or metabolites whose 
concentration can be correlated to clinical situations. 
Usually, these molecules are not suitable for early 
diagnosis or to follow clinical evolution. Therefore, 
strategies to evaluate the complete molecular scenario 
– early diagnosis, diagnosis and clinical evolution – 
are necessary. 
The potential of proteins for a large-scale 
diagnosis depends on cheap and preferably 
noninvasive strategies for screening. Bioinformatics 
strategies and solutions to work on different types of 
data: from biological related data to personal and 
clinical information’s, is the best approach. Data 
integration by these methods is an asset to predict the 
pathological status before clinical outcomes. 
This work explores the potential of saliva protein 
profile obtained by capillary electrophoresis – the 
SalivaPrint - as a strategy to obtain signatures of 
health/disease states. The application of 
computational methods (machine learning strategies) 
will allow the establishment of a signature that 
characterizes the healthy individual and how it varies 
with diverse factors.  
At this time, we are only interested in establishing 
the entire SalivaPrint methodology, from capillary 
electrophoresis to determining which factors 
influence the protein profile (of healthy individuals) 
including the creation of the database that stores all 
this information. 
3 METHODOLOGY 
This study was approved by the Ethics Committee of 
the Portuguese Catholic University (UCP). In 
addition, donors will be asked, prior to any collection, 
the consent for samples’ collection. All work will be 
carried out in accordance with the principles of the 
Helsinki declaration, as reviewed in 2008. 
In order to achieve the proposed objectives, the 
strategy presented in figure 1 will be followed: 
 
Figure 1: Flowchart of proposed strategy plan. 
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3.1 Questionnaire Preparation to 
Characterize the Biological Sample 
An online filling questionnaire will be created using 
Qualtrics® software, for the collection of clinical and 
personal information. 
Questions will be defined to address the 
individual's personal data and clinical status 
(SalivaTec Donor Form). Each donor will be 
observed by a dentist (collaboration with the Dental 
Clinic of UCP), for oral health status evaluation, 
taking into account the PSR index (Periodontal 
Screening Recording) and DMFT (Decayed, Missing, 
Filled Teeth) (Anón, 2002; Schuller and Holst, 2001). 
3.2 Collection and Processing of Saliva 
Samples 
To define the protein profile of healthy individuals, 
samples of non-stimulated saliva will be collected, 
using an established protocol (Rosa et al., 2016), from 
patients from the dental clinic of the Portuguese 
Catholic University and from seniors in the Senior 
Activity program from the municipality of Viseu. The 
criteria for exclusion of healthy donors were defined 
according to the literature: patients with oral or 
systemic pathology; intake of regular or punctual 
medication in the last 30 days; antibiotic 
administration in the last 3 months; never subjected 
to radiological or chemical treatment (Mozaffari et 
al., 2019; Murr et al., 2017; Wang et al., 2015). 
Samples will be categorized into groups of different 
ages and genders. 
These collections will be made under partnerships 
already established with each institution. 
Total protein concentration, pH and volume of 
each sample will be determined. 
3.3 Determination of the Total Profile 
of Proteins by Capillary 
Electrophoresis 
Saliva protein profile (SalivaPrint) will be determined 
by capillary electrophoresis, using the Experion™ 
Automated Electrophoresis System (BioRad) in 
standard protein chips (Experion™ Pro260 Analysis 
Kit). The samples will be analyzed according to the 
technical specifications provided by BioRad. 
Protein profile and the quantification of bands 
will be obtained using the Experion™ Software, 
version 3.20. 
3.4 Determination of Factors 
Influencing Health-SalivaPrint 
The clustering of profiles will be tested according to 
potentially influencing factors of salivary proteome 
[age, gender and circadian rhythm (Castagnola et al., 
2017), among others].  
For this, a variety of statistical analysis models 
(e.g. Kruskall-Wallis) will be applied for comparing 
each profile between influence groups created. Also, 
data classification techniques will be implemented 
with high robustness and effectiveness, such as 
Random Forest, as well as approaches based on 
unsupervised learning models for clustering analysis. 
The performance of the different existing techniques, 
the pertinence ratio of the data involved, the 
effectiveness of the quality of the results obtained, 
analyzing accuracy and tests of positive and negative 
diagnoses, among others, will be evaluated.  
Parallelly a distance profile will be determined 
between the mean profile of healthy individuals’ 
groups formed according impact factors on protein 
profile. This approach will allow the identification of 
the molecular mass corresponding to the peaks that 
demonstrate to be different. A threshold will be set at 
half peak height to identify these intervals. This step 
will allow the association of potential proteins in 
these ranges using saliva protein database 
SalivaTecDB (http://salivatec.viseu.ucp.pt/salivatec-
db). The area of each peak in each profile will be 
compared between all individual profiles, using a t-
test, in order to identify peaks characteristic of each 
factor. 
From these analyses will result intervals of 
molecular masses corresponding to proteins of 
interest (later confirmed by mass spectrometry). 
3.5 Construction of the Database for 
the Storage of SalivaPrints 
Protein profiles representing different conditions will 
result from this work and will be gathered in 
SalivaPrint database. Each SalivaPrint will be linked 
to the metadata collected in the questionnaires 
developed in 3.1. Tools will be developed to 
categorize, edit, visualize and export the data 
obtained to different formats, creating the necessary 
conditions for its use in the development of 
computational strategies for analysis and comparison 
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4 PRELIMINARY RESULTS 
The implementation of the proposed strategy (Figure 
1) has so far yielded the results described below. 
So far it has been possible to collect 79 samples 
meeting the defined inclusion criteria (Table 1) and 
the metadata associated with each sample using the 
questionnaire developed by us. 
Table 1: Number of saliva samples collected form healthy 















<13 12 4 24 
13-24 14 10 39 
25-50 22 17 16 
Total 48 31 79 
A protein profile for each gender (Female n=48; 
Male n=31) was built (Figure 2 a), according to the 
methodology described in the section 3.3. 
In order to determine how gender impact, the 
saliva total protein profile in health individuals 
(Health-SalivaPrint) a Kruskal-Wallis hypothesis test 
was applied (Figure 2). In top graph we could see the 
protein profiles from Female (red) and Male (blue) 
individuals. When Kruskal-Wallis test is applied, on 
lower graph the higher peak (green) with lower p 
value (yellow) corresponds to molecular weight 
where it exists a significant difference between 
genders, so the gender characteristic signature. 
A distance profile for each gender was built 
according to the methodology described earlier. The 
comparison of the mean-profile obtained from saliva 
of Female and Male individuals was used to establish 
a distance-profile (Figure 3). This distance profile 
reflects the molecular weight (MW) range 
corresponding to the proteins that are altered between 
genders. The creation of the distance profile allows 
the identification of the specific molecular mass 
according to different expressed peaks on each group 
(Figure 3). 
The t-test applied on half-peak areas of all profiles 
showed the main differences were found in 2 of the 
typical 6 peaks of the saliva protein profile. Within 
these peaks, the MW ranges of peak 5 (58.5 - 63.2 
kDa) and peak 6 (66.8 - 74.2 kDa).  
 
 
Figure 2: Application of the Kruskal-Wallis hypotheses test in determining profile signatures for gender identification. In a), 
red lines correspond to the profiles of female individuals and blue lines to the profiles of male individuals. In b) the green line 
corresponds to the test value and the yellow line to the p value. Higher hypothesis test value (green) and lower p value (yellow) 
correspond to the molecular weight were exist a clear difference on fluorescence between genders. 
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Figure 3: Protein profile distribution in Female (----) and Male (– – –) individuals. a) Female and Male mean-profile 
corresponding to the average of fluorescence per molecular weight. The standard deviations are represented by the vertical 
error lines. b) Protein profile for Female (----) and Male (– – –) and the distance-profile (–). Shaded areas correspond to the 
MW range of the proteins most altered between genders. 
Once the distance profile and the respective MW 
ranges are established, it is possible, use 
SalivaTecDB (Figure 4), to associate potential 
proteins with molecular mass within the defined 
ranges and after that confirmed by mass 
spectrometry. 
 
Figure 4: SalivaTecDB homepage. SalivaTecDB is 
dedicated to the annotation and characterization of proteins, 
miRNAs and Microorganisms present in the oral cavity, 
associated with oral or systemic mechanisms. This database 
was developed as a tool to be used by researchers working 
in Salivary Diagnostics. 
5 FUTURE WORK 
Currently we are developing the Python scripts for: 
data acquiring (from electrophoresis system) and 
treatment (profile alignment, peak determination and 
peak area calculation). These scripts will allow the 
total protein profile comparing between individuals 
and groups, with peak areas for statistical analysis, as 
well as analysis with machine learning strategies. The 
application of machine learning, for example Random 
Forest based on unsupervised models, allow the 
clusterization according to impact factors on profile 
(if it’s the case) and thus define a characteristic 
Health-SalivaPrint. 
6 CONCLUSIONS 
This paper presents the SalivaPrint strategy and 
preliminary results already obtained with this 
approach. This work already allowed us to develop 
the methodologies that permits to obtain the total 
protein profile of health individuals (in a convenience 
sample). Through the analysis of these profiles it is 
possible to associate the potential proteins more 
representative of the differences between them using 
SalivaTecDB. The application of the Kruskal-Wallis 
test is a first approach on the identification of 
signatures, although there still need for other analysis 
to confirm the results. 
Future work will be directed to python scripts 
development to acquire aligned protein profiles and 
determine the factors that influence the profile, as 
well as establish the machine learning strategy for 
cluster determination and its association to database 
(SalivaPrintDB). 
It is expected with this work to use the database 
with SalivaPrints associated with an unsupervised 
machine learning algorithm that allows protein 
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patterns recognition through profiles and personal 
data, without defined diagnosis, pathology or health 
situations. This approach will consider the 
morphology of the protein profile obtained with 
capillary electrophoresis in an automated manner and 
the influencing factors of saliva proteome, namely, 
the total protein concentration, age, gender and inter-
individual and intra-individual variability. These 
variables will be analyzed through the application of 
supervised analysis models in a first phase to identify 
the influence of each factor in the profile. Later with 
a higher number of individuals we resorted to 
unsupervised analysis models. 
For this strategy to be used for diagnosis 
purposes, it is necessary to compare Health-
SalivaPrint with a Disease-SalivaPrint. Since 
differences in saliva protein profiles have been 
observed in healthy people, depending on age and 
gender, it is important to take this into account in 
order to isolate the effect of the disease from the 
effects of these parameters. 
This type of work is essential to find less invasive 
forms of diagnosis that take into account all the 
molecular and physiological variability of the 
individual. 
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